Related references
Note: Only part of the references are listed.Natural Products Isolated from Oriental Medicinal Herbs Inactivate Zika Virus
Mariana N. Batista et al.
VIRUSES-BASEL (2019)
Therapies based on targeting Epstein-Barr virus lytic replication for EBV-associated malignancies
Hongde Li et al.
CANCER SCIENCE (2018)
Emodin as a selective proliferative inhibitor of vascular smooth muscle cells versus endothelial cells suppress arterial intima formation
Kang Xu et al.
LIFE SCIENCES (2018)
Emodin induces apoptosis in human hepatocellular carcinoma HepaRG cells via the mitochondrial caspase-dependent pathway
Xiaoxv Dong et al.
ONCOLOGY REPORTS (2018)
Emodin Inhibition of Influenza A Virus Replication and Influenza Viral Pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB Pathways
Jian-Ping Dai et al.
MOLECULES (2017)
Epstein-Barr virus BRLF1 induces genomic instability and progressive malignancy in nasopharyngeal carcinoma cells
Sheng-Yen Huang et al.
ONCOTARGET (2017)
Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer (Withdrawn Publication)
Qing Tang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin
Chung-Chun Wu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes
Chung-Chun Wu et al.
ANTIVIRAL RESEARCH (2016)
Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics
Xiaoxv Dong et al.
PHYTOTHERAPY RESEARCH (2016)
EBV reactivation as a target of luteolin to repress NPC tumorigenesis
Chung-Chun Wu et al.
ONCOTARGET (2016)
Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL
Zohaib Alam et al.
ANTIVIRAL RESEARCH (2015)
Inhibition of integrin-linked kinase expression by emodin through crosstalk of AMPKα and ERK1/2 signaling and reciprocal interplay of Sp1 and c-Jun
Qing Tang et al.
CELLULAR SIGNALLING (2015)
Inhibition of Epstein-Barr Virus Lytic Cycle by an Ethyl Acetate Subfraction Separated from Polygonum cuspidatum Root and Its Major Component, Emodin
Ching-Yi Yiu et al.
MOLECULES (2014)
Switching of EBV cycles between latent and lytic states
Takayuki Murata et al.
REVIEWS IN MEDICAL VIROLOGY (2014)
Regulation of the latent-lytic switch in Epstein-Barr virus
Shannon C. Kenney et al.
SEMINARS IN CANCER BIOLOGY (2014)
Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma
Shih-Hsin Chiu et al.
ONCOTARGET (2014)
Inhibition of Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma Cells by Dietary Sulforaphane
Chung-Chun Wu et al.
MOLECULAR CARCINOGENESIS (2013)
In Vitro and in Vivo Studies of the Inhibitory Effects of Emodin Isolated from Polygonum cuspidatum on Coxsakievirus B4
Zhao Liu et al.
MOLECULES (2013)
Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targets
Alessandra De Leo et al.
ANTIVIRAL RESEARCH (2012)
Epstein-Barr Virus BGLF4 Kinase Retards Cellular S-Phase Progression and Induces Chromosomal Abnormality
Yu-Hsin Chang et al.
PLOS ONE (2012)
The Synergistic Effect of Chemical Carcinogens Enhances Epstein-Barr Virus Reactivation and Tumor Progression of Nasopharyngeal Carcinoma Cells
Chih-Yeu Fang et al.
PLOS ONE (2012)
The effect of emodin, an anthraquinone derivative extracted from the roots of Rheum tanguticum, against herpes simplex virus in vitro and in vivo
Hai-Rong Xiong et al.
JOURNAL OF ETHNOPHARMACOLOGY (2011)
Inhibition of the Epstein-Barr virus lytic cycle by protoapigenone
Chao-Ping Tung et al.
JOURNAL OF GENERAL VIROLOGY (2011)
Fluctuations of Epstein-Barr Virus Serological Antibodies and Risk for Nasopharyngeal Carcinoma: A Prospective Screening Study with a 20-Year Follow-Up
Su-Mei Cao et al.
PLOS ONE (2011)
Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy
Sheng-Fa Su et al.
Chinese Journal of Cancer (2011)
Inhibition of the Epstein-Barr virus lytic cycle by moronic acid
Fang-Rong Chang et al.
ANTIVIRAL RESEARCH (2010)
Epstein-Barr Virus DNase (BGLF5) induces genomic instability in human epithelial cells
Chung-Chun Wu et al.
NUCLEIC ACIDS RESEARCH (2010)
Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells
Chih-Yeu Fang et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Inhibition of the Epstein-Barr Virus Lytic Cycle by Andrographolide
Tsuey-Pin Lin et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures
C-Y Hsiang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Regulation of Sp1 by cell cycle related proteins
Alicia Tapias et al.
CELL CYCLE (2008)
Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction
Tin-Yun Ho et al.
ANTIVIRAL RESEARCH (2007)
Epstein-Baff virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies
G Cabras et al.
JOURNAL OF CLINICAL VIROLOGY (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells
MT Liu et al.
ONCOGENE (2004)
Transcriptional regulation of the human Sp1 gene promoter by the specificity protein (Sp) family members nuclear factor Y (NF-Y) and E2F
M Nicolás et al.
BIOCHEMICAL JOURNAL (2003)
Inhibition of Epstein-Barr virus lytic cycle by (-)-epigallocatechin gallate
LK Chang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates
JC Lin et al.
BRITISH JOURNAL OF CANCER (2003)
The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells
M Hergenhahn et al.
MOLECULAR CARCINOGENESIS (2002)
Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men
YC Chien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The cellular protein PRA1 modulates the anti-apoptotic activity of Epstein-Barr virus BHRF1, a homologue of Bcl-2, through direct interaction
LY Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma
AWM Lee et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
